Global Antihelminthics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Antihelminthics market report explains the definition, types, applications, major countries, and major players of the Antihelminthics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Novartis

    • Sanofi

    • AstraZeneca

    • ALLERGAN

    • Abbott

    • Astellas Pharma

    • Pfizer

    • GlaxoSmithKline

    • Johnson & Johnson

    • Bayer

    • ZEISS International

    • Abbott

    • Mentis Pharma

    • Sanofi

    By Type:

    • Benzimidazoles

    • Abamectin

    • Salicylanilides

    • Praziquantel

    • Other

    By End-User:

    • Schistosomiasis

    • Fasciolasis

    • Filariasis

    • Angiostrongylosis

    • Ascariasis

    • Giardiasis

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Antihelminthics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Antihelminthics Outlook to 2028- Original Forecasts

    • 2.2 Antihelminthics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Antihelminthics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Antihelminthics Market- Recent Developments

    • 6.1 Antihelminthics Market News and Developments

    • 6.2 Antihelminthics Market Deals Landscape

    7 Antihelminthics Raw Materials and Cost Structure Analysis

    • 7.1 Antihelminthics Key Raw Materials

    • 7.2 Antihelminthics Price Trend of Key Raw Materials

    • 7.3 Antihelminthics Key Suppliers of Raw Materials

    • 7.4 Antihelminthics Market Concentration Rate of Raw Materials

    • 7.5 Antihelminthics Cost Structure Analysis

      • 7.5.1 Antihelminthics Raw Materials Analysis

      • 7.5.2 Antihelminthics Labor Cost Analysis

      • 7.5.3 Antihelminthics Manufacturing Expenses Analysis

    8 Global Antihelminthics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Antihelminthics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Antihelminthics Export by Region (Top 10 Countries) (2017-2028)

    9 Global Antihelminthics Market Outlook by Types and Applications to 2022

    • 9.1 Global Antihelminthics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Benzimidazoles Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Abamectin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Salicylanilides Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Praziquantel Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Antihelminthics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Schistosomiasis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Fasciolasis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Filariasis Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Angiostrongylosis Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Ascariasis Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Giardiasis Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Antihelminthics Market Analysis and Outlook till 2022

    • 10.1 Global Antihelminthics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Antihelminthics Consumption (2017-2022)

      • 10.2.2 Canada Antihelminthics Consumption (2017-2022)

      • 10.2.3 Mexico Antihelminthics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Antihelminthics Consumption (2017-2022)

      • 10.3.2 UK Antihelminthics Consumption (2017-2022)

      • 10.3.3 Spain Antihelminthics Consumption (2017-2022)

      • 10.3.4 Belgium Antihelminthics Consumption (2017-2022)

      • 10.3.5 France Antihelminthics Consumption (2017-2022)

      • 10.3.6 Italy Antihelminthics Consumption (2017-2022)

      • 10.3.7 Denmark Antihelminthics Consumption (2017-2022)

      • 10.3.8 Finland Antihelminthics Consumption (2017-2022)

      • 10.3.9 Norway Antihelminthics Consumption (2017-2022)

      • 10.3.10 Sweden Antihelminthics Consumption (2017-2022)

      • 10.3.11 Poland Antihelminthics Consumption (2017-2022)

      • 10.3.12 Russia Antihelminthics Consumption (2017-2022)

      • 10.3.13 Turkey Antihelminthics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Antihelminthics Consumption (2017-2022)

      • 10.4.2 Japan Antihelminthics Consumption (2017-2022)

      • 10.4.3 India Antihelminthics Consumption (2017-2022)

      • 10.4.4 South Korea Antihelminthics Consumption (2017-2022)

      • 10.4.5 Pakistan Antihelminthics Consumption (2017-2022)

      • 10.4.6 Bangladesh Antihelminthics Consumption (2017-2022)

      • 10.4.7 Indonesia Antihelminthics Consumption (2017-2022)

      • 10.4.8 Thailand Antihelminthics Consumption (2017-2022)

      • 10.4.9 Singapore Antihelminthics Consumption (2017-2022)

      • 10.4.10 Malaysia Antihelminthics Consumption (2017-2022)

      • 10.4.11 Philippines Antihelminthics Consumption (2017-2022)

      • 10.4.12 Vietnam Antihelminthics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Antihelminthics Consumption (2017-2022)

      • 10.5.2 Colombia Antihelminthics Consumption (2017-2022)

      • 10.5.3 Chile Antihelminthics Consumption (2017-2022)

      • 10.5.4 Argentina Antihelminthics Consumption (2017-2022)

      • 10.5.5 Venezuela Antihelminthics Consumption (2017-2022)

      • 10.5.6 Peru Antihelminthics Consumption (2017-2022)

      • 10.5.7 Puerto Rico Antihelminthics Consumption (2017-2022)

      • 10.5.8 Ecuador Antihelminthics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Antihelminthics Consumption (2017-2022)

      • 10.6.2 Kuwait Antihelminthics Consumption (2017-2022)

      • 10.6.3 Oman Antihelminthics Consumption (2017-2022)

      • 10.6.4 Qatar Antihelminthics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Antihelminthics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Antihelminthics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Antihelminthics Consumption (2017-2022)

      • 10.7.2 South Africa Antihelminthics Consumption (2017-2022)

      • 10.7.3 Egypt Antihelminthics Consumption (2017-2022)

      • 10.7.4 Algeria Antihelminthics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Antihelminthics Consumption (2017-2022)

      • 10.8.2 New Zealand Antihelminthics Consumption (2017-2022)

    11 Global Antihelminthics Competitive Analysis

    • 11.1 Novartis

      • 11.1.1 Novartis Company Details

      • 11.1.2 Novartis Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Novartis Antihelminthics Main Business and Markets Served

      • 11.1.4 Novartis Antihelminthics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sanofi

      • 11.2.1 Sanofi Company Details

      • 11.2.2 Sanofi Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sanofi Antihelminthics Main Business and Markets Served

      • 11.2.4 Sanofi Antihelminthics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 AstraZeneca

      • 11.3.1 AstraZeneca Company Details

      • 11.3.2 AstraZeneca Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 AstraZeneca Antihelminthics Main Business and Markets Served

      • 11.3.4 AstraZeneca Antihelminthics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 ALLERGAN

      • 11.4.1 ALLERGAN Company Details

      • 11.4.2 ALLERGAN Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 ALLERGAN Antihelminthics Main Business and Markets Served

      • 11.4.4 ALLERGAN Antihelminthics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Abbott

      • 11.5.1 Abbott Company Details

      • 11.5.2 Abbott Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Abbott Antihelminthics Main Business and Markets Served

      • 11.5.4 Abbott Antihelminthics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Astellas Pharma

      • 11.6.1 Astellas Pharma Company Details

      • 11.6.2 Astellas Pharma Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Astellas Pharma Antihelminthics Main Business and Markets Served

      • 11.6.4 Astellas Pharma Antihelminthics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Pfizer

      • 11.7.1 Pfizer Company Details

      • 11.7.2 Pfizer Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Pfizer Antihelminthics Main Business and Markets Served

      • 11.7.4 Pfizer Antihelminthics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 GlaxoSmithKline

      • 11.8.1 GlaxoSmithKline Company Details

      • 11.8.2 GlaxoSmithKline Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 GlaxoSmithKline Antihelminthics Main Business and Markets Served

      • 11.8.4 GlaxoSmithKline Antihelminthics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Johnson & Johnson

      • 11.9.1 Johnson & Johnson Company Details

      • 11.9.2 Johnson & Johnson Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Johnson & Johnson Antihelminthics Main Business and Markets Served

      • 11.9.4 Johnson & Johnson Antihelminthics Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Bayer

      • 11.10.1 Bayer Company Details

      • 11.10.2 Bayer Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Bayer Antihelminthics Main Business and Markets Served

      • 11.10.4 Bayer Antihelminthics Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 ZEISS International

      • 11.11.1 ZEISS International Company Details

      • 11.11.2 ZEISS International Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 ZEISS International Antihelminthics Main Business and Markets Served

      • 11.11.4 ZEISS International Antihelminthics Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Abbott

      • 11.12.1 Abbott Company Details

      • 11.12.2 Abbott Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Abbott Antihelminthics Main Business and Markets Served

      • 11.12.4 Abbott Antihelminthics Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Mentis Pharma

      • 11.13.1 Mentis Pharma Company Details

      • 11.13.2 Mentis Pharma Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Mentis Pharma Antihelminthics Main Business and Markets Served

      • 11.13.4 Mentis Pharma Antihelminthics Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Sanofi

      • 11.14.1 Sanofi Company Details

      • 11.14.2 Sanofi Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Sanofi Antihelminthics Main Business and Markets Served

      • 11.14.4 Sanofi Antihelminthics Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    12 Global Antihelminthics Market Outlook by Types and Applications to 2028

    • 12.1 Global Antihelminthics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Benzimidazoles Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Abamectin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Salicylanilides Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Praziquantel Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Antihelminthics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Schistosomiasis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Fasciolasis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Filariasis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Angiostrongylosis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Ascariasis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Giardiasis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.7 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Antihelminthics Market Analysis and Outlook to 2028

    • 13.1 Global Antihelminthics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Antihelminthics Consumption Forecast (2022-2028)

      • 13.2.2 Canada Antihelminthics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Antihelminthics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.2 UK Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.3 Spain Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.5 France Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.6 Italy Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.8 Finland Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.9 Norway Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.11 Poland Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.12 Russia Antihelminthics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Antihelminthics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Antihelminthics Consumption Forecast (2022-2028)

      • 13.4.2 Japan Antihelminthics Consumption Forecast (2022-2028)

      • 13.4.3 India Antihelminthics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Antihelminthics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Antihelminthics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Antihelminthics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Antihelminthics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Antihelminthics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Antihelminthics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Antihelminthics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Antihelminthics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Antihelminthics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Antihelminthics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Antihelminthics Consumption Forecast (2022-2028)

      • 13.5.3 Chile Antihelminthics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Antihelminthics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Antihelminthics Consumption Forecast (2022-2028)

      • 13.5.6 Peru Antihelminthics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Antihelminthics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Antihelminthics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Antihelminthics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Antihelminthics Consumption Forecast (2022-2028)

      • 13.6.3 Oman Antihelminthics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Antihelminthics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Antihelminthics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Antihelminthics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Antihelminthics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Antihelminthics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Antihelminthics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Antihelminthics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Antihelminthics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Antihelminthics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Antihelminthics

    • Figure of Antihelminthics Picture

    • Table Global Antihelminthics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Antihelminthics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Benzimidazoles Consumption and Growth Rate (2017-2022)

    • Figure Global Abamectin Consumption and Growth Rate (2017-2022)

    • Figure Global Salicylanilides Consumption and Growth Rate (2017-2022)

    • Figure Global Praziquantel Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Schistosomiasis Consumption and Growth Rate (2017-2022)

    • Figure Global Fasciolasis Consumption and Growth Rate (2017-2022)

    • Figure Global Filariasis Consumption and Growth Rate (2017-2022)

    • Figure Global Angiostrongylosis Consumption and Growth Rate (2017-2022)

    • Figure Global Ascariasis Consumption and Growth Rate (2017-2022)

    • Figure Global Giardiasis Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Antihelminthics Consumption by Country (2017-2022)

    • Table North America Antihelminthics Consumption by Country (2017-2022)

    • Figure United States Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Canada Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Mexico Antihelminthics Consumption and Growth Rate (2017-2022)

    • Table Europe Antihelminthics Consumption by Country (2017-2022)

    • Figure Germany Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure UK Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Spain Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Belgium Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure France Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Italy Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Denmark Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Finland Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Norway Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Sweden Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Poland Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Russia Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Turkey Antihelminthics Consumption and Growth Rate (2017-2022)

    • Table APAC Antihelminthics Consumption by Country (2017-2022)

    • Figure China Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Japan Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure India Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Thailand Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Singapore Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Philippines Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Antihelminthics Consumption and Growth Rate (2017-2022)

    • Table South America Antihelminthics Consumption by Country (2017-2022)

    • Figure Brazil Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Colombia Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Chile Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Argentina Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Peru Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Antihelminthics Consumption and Growth Rate (2017-2022)

    • Table GCC Antihelminthics Consumption by Country (2017-2022)

    • Figure Bahrain Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Oman Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Qatar Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Antihelminthics Consumption and Growth Rate (2017-2022)

    • Table Africa Antihelminthics Consumption by Country (2017-2022)

    • Figure Nigeria Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure South Africa Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Egypt Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure Algeria Antihelminthics Consumption and Growth Rate (2017-2022)

    • Table Oceania Antihelminthics Consumption by Country (2017-2022)

    • Figure Australia Antihelminthics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Antihelminthics Consumption and Growth Rate (2017-2022)

    • Table Novartis Company Details

    • Table Novartis Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Antihelminthics Main Business and Markets Served

    • Table Novartis Antihelminthics Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Antihelminthics Main Business and Markets Served

    • Table Sanofi Antihelminthics Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Antihelminthics Main Business and Markets Served

    • Table AstraZeneca Antihelminthics Product Portfolio

    • Table ALLERGAN Company Details

    • Table ALLERGAN Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table ALLERGAN Antihelminthics Main Business and Markets Served

    • Table ALLERGAN Antihelminthics Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Antihelminthics Main Business and Markets Served

    • Table Abbott Antihelminthics Product Portfolio

    • Table Astellas Pharma Company Details

    • Table Astellas Pharma Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Antihelminthics Main Business and Markets Served

    • Table Astellas Pharma Antihelminthics Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Antihelminthics Main Business and Markets Served

    • Table Pfizer Antihelminthics Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Antihelminthics Main Business and Markets Served

    • Table GlaxoSmithKline Antihelminthics Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Antihelminthics Main Business and Markets Served

    • Table Johnson & Johnson Antihelminthics Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Antihelminthics Main Business and Markets Served

    • Table Bayer Antihelminthics Product Portfolio

    • Table ZEISS International Company Details

    • Table ZEISS International Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table ZEISS International Antihelminthics Main Business and Markets Served

    • Table ZEISS International Antihelminthics Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Antihelminthics Main Business and Markets Served

    • Table Abbott Antihelminthics Product Portfolio

    • Table Mentis Pharma Company Details

    • Table Mentis Pharma Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mentis Pharma Antihelminthics Main Business and Markets Served

    • Table Mentis Pharma Antihelminthics Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Antihelminthics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Antihelminthics Main Business and Markets Served

    • Table Sanofi Antihelminthics Product Portfolio

    • Figure Global Benzimidazoles Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Abamectin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Salicylanilides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Praziquantel Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Schistosomiasis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fasciolasis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Filariasis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Angiostrongylosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ascariasis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Giardiasis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antihelminthics Consumption Forecast by Country (2022-2028)

    • Table North America Antihelminthics Consumption Forecast by Country (2022-2028)

    • Figure United States Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Antihelminthics Consumption Forecast by Country (2022-2028)

    • Figure Germany Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Antihelminthics Consumption Forecast by Country (2022-2028)

    • Figure China Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Antihelminthics Consumption Forecast by Country (2022-2028)

    • Figure Brazil Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Antihelminthics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Antihelminthics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Antihelminthics Consumption Forecast by Country (2022-2028)

    • Figure Australia Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Antihelminthics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.